Clinical and Translational Radiation Oncology | 2021
Excessive waitlists and delays to treatment with low-dose-rate brachytherapy predict an increased risk of recurrence and metastases in intermediate-risk prostatic carcinoma
Abstract
Highlights • Resource constraints have led to prolonged wait-times for prostate brachytherapy.• Increased wait times predict a significant increase in recurrence and metastases.• Better resource planning is needed to reduce management delays & improve outcomes.